Overview

Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine if alpha lipoic acid is an effective treatment for chronic inflammatory demyelinating polyneuropathy (CIDP).
Phase:
Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
Collins Medical Trust
Treatments:
Thioctic Acid